about
Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson's disease.The Progressive BSSG Rat Model of Parkinson's: Recapitulating Multiple Key Features of the Human DiseaseParkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and DiagnosisAnxiety- and depression-like behavior in mice lacking the CD157/BST1 gene, a risk factor for Parkinson's disease.The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson's disease or clinically uncertain parkinsonism: a systematic review.Diagnosing and treating neurogenic orthostatic hypotension in primary care.Cardiac sympathetic denervation in 6-OHDA-treated nonhuman primates.Non-motor Parkinson's: integral to motor Parkinson's, yet often neglected.Premotor and nonmotor features of Parkinson's disease.Brain imaging of vesicular monoamine transporter type 2 in healthy aging subjects by 18F-FP-(+)-DTBZ PET.Identifying the clusters within nonmotor manifestations in early Parkinson's disease by using unsupervised cluster analysis.Motor Sequence Learning and Consolidation in Unilateral De Novo Patients with Parkinson's Disease.The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward.Proteomic profiling in MPTP monkey model for early Parkinson disease biomarker discoveryIdiopathic REM sleep behaviour disorder in the development of Parkinson's diseaseTraffic-Related Air Pollution and Parkinson's Disease in Denmark: A Case-Control Study.Association of brain pathology with the progression of frailty in older adults.Parkinsonism in Older Adults and Its Association With Adverse Health Outcomes and NeuropathologyHousehold organophosphorus pesticide use and Parkinson's disease.Critical role of calpain in spinal cord degeneration in Parkinson's diseaseTotal daily activity declines more rapidly with increasing age in older adultsGastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments.Prerequisites to launch neuroprotective trials in Parkinson's disease: an industry perspective.The significance of defining preclinical or prodromal Parkinson's disease.Is there a need to redefine Parkinson's disease?Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker.Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies.The Concept of Prodromal Parkinson's Disease.Current and investigational non-dopaminergic agents for management of motor symptoms (including motor complications) in Parkinson's disease.Position Emission Tomography/Single-Photon Emission Tomography Neuroimaging for Detection of Premotor Parkinson's Disease.Ghrelin and Neurodegenerative Disorders-a Review.Biomarkers in Prodromal Parkinson Disease: a Qualitative Review.Parkinson's Disease and Neurodegeneration: GABA-Collapse HypothesisNon-human primate models of PD to test novel therapies.Incident parkinsonism in older adults without Parkinson disease.Ventilatory Response to Hypercapnia Predicts Dementia with Lewy Bodies in Late-Onset Major Depressive Disorder.Neuroimaging and clinical features in adults with a 22q11.2 deletion at risk of Parkinson's disease.Non-motor multiple system atrophy associated with sudden death: pathological observations of autonomic nuclei.A population-based study on combined markers for early Parkinson's disease.Can we define "pre-motor" Parkinson's disease?
P2860
Q27310355-ED8D3E8F-BFD1-497A-91FE-37A7200BF139Q27315090-CC136CAE-BB5E-4641-A0C9-50010A1EF56DQ28384572-50E8C46C-EBA1-4756-AFFF-E644B463AD9EQ30438962-0DF2B87D-CA70-445F-8308-23FC07EB3957Q30635471-E6694BF1-497F-4809-A2E1-2658C44CB11CQ33165773-0374FB07-E513-4608-97B4-DF914E1FDE3FQ34061568-AC913554-4C81-48D5-AAA9-9B902F301696Q34239492-D8A3EAEF-DB6B-4D56-918B-73199554C306Q34274224-861F0FCE-B254-4975-A4F6-ED2B45F2077EQ34375709-441A4AD8-154B-4696-B6A8-3961C7971136Q35124218-7D9A04DC-286B-4B7D-A00E-6A6EF177A650Q35722836-181F6A6A-2C59-47F1-B5D1-266B81262F93Q36332532-0C2ADA1F-368F-4E18-B673-CCD40014FC00Q36598403-9D9A177F-0689-4F4C-8F85-9B2A9E72D09BQ36656691-2BBCADC0-A86F-4A8E-8FC5-ACF75E768DE5Q36675511-D3350B7C-C18E-4E7F-B04A-6108E8D19BB0Q37027314-83246E16-02AA-4B8D-98D8-B4DF4DCED8DFQ37238300-EF960506-7A07-4C00-9823-4BA115B304AFQ37253501-2FE65D96-C877-421C-B513-738B65F7F172Q37384896-0B1BE45E-B13B-4AC7-BB0F-75483EBD8AA3Q37469194-FFD210CA-6222-4FBB-8244-40886AC0A481Q37516494-0946A474-83A5-46C2-B65C-C0DDCAB701F0Q38003066-331375E8-6C5A-42DB-8974-3277335F72E3Q38003068-6B85D47D-3299-4445-89ED-1DA155237657Q38110209-0C1397AA-E943-4D36-A0E5-24FFE40568CCQ38174524-6FFD9D27-23FD-4085-8622-41377C4F7EC9Q38248883-F0091DD6-40FF-4BB4-A81D-A728667785A8Q38612230-785E64A2-E044-40B2-9936-BEB4EFEC7E71Q38636630-4AA73A38-9F4D-4133-B087-7C86E757CA7FQ38699508-2A16BF73-3A0B-47A1-95D5-A7B847ED633FQ38711350-455D9853-3EC2-4130-94B7-BA308AFA88EFQ38788917-ACCAD34B-55D4-4332-B285-B1A054E63170Q38845589-CB4BDF26-D916-4DC7-B61A-91012106F694Q39229450-8E40B626-7A0C-4C54-A486-85A627433F48Q40637214-D4B918B6-13ED-4EEC-9A1C-8D7BA6226B10Q41949226-9632C5EC-F153-4441-B623-358B0BAEB533Q47759449-666DED16-C4F0-4EA7-AF5C-E184C485B162Q48307392-3882DB2F-B2B7-453B-B578-DC283E3376A2Q48397754-437FAD1C-6CAD-48E5-8EFD-B4A649B9DCEAQ48565241-F2511A3C-1200-41AC-A4F9-AD47C33E11C1
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Premotor Parkinson's disease: concepts and definitions
@ast
Premotor Parkinson's disease: concepts and definitions
@en
type
label
Premotor Parkinson's disease: concepts and definitions
@ast
Premotor Parkinson's disease: concepts and definitions
@en
prefLabel
Premotor Parkinson's disease: concepts and definitions
@ast
Premotor Parkinson's disease: concepts and definitions
@en
P2860
P356
P1433
P1476
Premotor Parkinson's disease: concepts and definitions
@en
P2860
P304
P356
10.1002/MDS.24954
P407
P577
2012-04-01T00:00:00Z